JP2022501483A5 - - Google Patents

Info

Publication number
JP2022501483A5
JP2022501483A5 JP2021516652A JP2021516652A JP2022501483A5 JP 2022501483 A5 JP2022501483 A5 JP 2022501483A5 JP 2021516652 A JP2021516652 A JP 2021516652A JP 2021516652 A JP2021516652 A JP 2021516652A JP 2022501483 A5 JP2022501483 A5 JP 2022501483A5
Authority
JP
Japan
Prior art keywords
cationic polymer
pharmaceutical composition
composition according
group
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021516652A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022501483A (ja
JP7539374B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/052110 external-priority patent/WO2020061430A1/en
Publication of JP2022501483A publication Critical patent/JP2022501483A/ja
Priority to JP2024073800A priority Critical patent/JP2024096280A/ja
Publication of JP2022501483A5 publication Critical patent/JP2022501483A5/ja
Application granted granted Critical
Publication of JP7539374B2 publication Critical patent/JP7539374B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021516652A 2018-09-20 2019-09-20 ボロン酸ポリマーおよび使用方法 Active JP7539374B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024073800A JP2024096280A (ja) 2018-09-20 2024-04-30 ボロン酸ポリマーおよび使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862734054P 2018-09-20 2018-09-20
US62/734,054 2018-09-20
PCT/US2019/052110 WO2020061430A1 (en) 2018-09-20 2019-09-20 Boronic acid polymers and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024073800A Division JP2024096280A (ja) 2018-09-20 2024-04-30 ボロン酸ポリマーおよび使用方法

Publications (3)

Publication Number Publication Date
JP2022501483A JP2022501483A (ja) 2022-01-06
JP2022501483A5 true JP2022501483A5 (enExample) 2024-05-15
JP7539374B2 JP7539374B2 (ja) 2024-08-23

Family

ID=69887916

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021516652A Active JP7539374B2 (ja) 2018-09-20 2019-09-20 ボロン酸ポリマーおよび使用方法
JP2024073800A Pending JP2024096280A (ja) 2018-09-20 2024-04-30 ボロン酸ポリマーおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024073800A Pending JP2024096280A (ja) 2018-09-20 2024-04-30 ボロン酸ポリマーおよび使用方法

Country Status (4)

Country Link
US (1) US20210403625A1 (enExample)
EP (1) EP3852768A4 (enExample)
JP (2) JP7539374B2 (enExample)
WO (1) WO2020061430A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020244556A1 (zh) * 2019-06-06 2020-12-10 上海交通大学 一种治疗或预防糖类物质相关疾病或病症的方法
EP4031553A4 (en) 2019-09-20 2023-11-01 Glyscend, Inc. POLYMERS WITH SUBSTITUTED PHENYLBORONIC ACID AND METHOD OF USE
CN116333197A (zh) * 2023-04-12 2023-06-27 厦门君德医药科技有限公司 胃肠道粘膜性聚合物、组合物及制备方法和应用
WO2026053928A1 (ja) * 2024-09-03 2026-03-12 株式会社シード 重合性ボロン酸化合物及び重合性カチオン性化合物を構成単位として含む高分子化合物及びその利用
CN120005104B (zh) * 2025-01-23 2025-10-31 武汉理工大学 一种pH响应型聚氨酯纳米材料、药物递送系统及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310844A (ja) * 1992-05-08 1993-11-22 Nippon Oil & Fats Co Ltd フェニルボロン酸基含有重合体
JPH07304971A (ja) * 1994-05-09 1995-11-21 Nippon Oil & Fats Co Ltd 糖応答性高分子材料
JP3867400B2 (ja) * 1998-05-08 2007-01-10 日本油脂株式会社 ボロン酸基含有単量体およびその重合体
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
ATE450274T1 (de) * 2002-07-22 2009-12-15 Psimei Pharmaceuticals Plc Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen
CA2546696A1 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Polymeric boronic acid derivatives as lipase inhibitors
US20110059176A1 (en) * 2007-11-22 2011-03-10 The University Of Tokyo Material for preventing tissue adhesion and material for preventing joint contracture
CN105017481B (zh) * 2010-02-24 2018-10-02 瑞立普萨公司 用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺
WO2013028548A2 (en) * 2011-08-19 2013-02-28 The Regents Of The University Of California Compositions and devices for the detection of biomarkers in the gastrointestinal tract and methods for making and using them
JP6784352B2 (ja) * 2015-05-11 2020-11-11 国立大学法人 東京医科歯科大学 インスリン送達用デバイス
EP3331499A4 (en) * 2015-08-06 2019-04-10 The Johns Hopkins University COMPOSITION AND METHOD FOR THE TREATMENT OF METABOLISM DISEASES

Similar Documents

Publication Publication Date Title
US20240254180A1 (en) Compositions of peptide inhibitors of interleukin-23 receptor
KR102105217B1 (ko) 다이메틸 푸마레이트를 함유하는 약학 조성물
CN1195499C (zh) 肠溶衣药用片剂及其生产方法
JP2022548699A5 (enExample)
ES2662373T3 (es) Formas de dosificación farmacéutica oral de liberación controlada que comprenden MGBG
TW201605435A (zh) 包含反丁烯二酸二甲酯之醫藥組成物
IL296355A (en) Oral hsp90 inhibitor formulations and related methods
TW201216962A (en) Formulation for solubility enhancement of poorly soluble drugs
CN104640546A (zh) 常山酮的剂型以及使用方法
JP2008533127A5 (enExample)
TW200827336A (en) New crystalline forms
JP2006008707A (ja) 下痢型過敏性腸症候群治療剤
EP4633620A1 (en) Stat3 inhibitors for use in the treatment of non-viral liver cancer
JP2022548698A5 (enExample)
JP2025506890A (ja) 治療用の化合物、製剤、およびそれらの使用
JP3763360B2 (ja) 下痢型過敏性腸症候群治療剤
CN101663035A (zh) 4－环丙基甲氧基－n－(3,5－二氯代－1－环氧－吡啶－4－基)－5－(甲氧基)吡啶－2－甲酰胺用于治疗与帕金森症有关的运动障碍的用途
CA2543757A1 (en) Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives
CN103664930B (zh) 一类含噻唑结构的化合物、其制备方法和用途
WO2012059937A1 (en) Modifies release pharmaceutical compositons for nsaids
US10471005B2 (en) Low dose pharmaceutical composition
US20250262165A1 (en) Compositions and methods for treating bile acid malabsorption
WO2020101584A1 (en) Sustained release acemetacin compositions
HK40069992A (en) Pharmaceutical compositions containing dimethyl fumarate
WO2025163534A1 (en) Crystal form of a peptide inhibitor of interleukin-23 receptor